Antibody, Primary Antibody, Monoclonal Antibody
anti-PD-L1 (Avelumab)
- Catalog Number : A510006
- Number : A510006-1mg
-
Size:
Qty : - Price : Request 詢價
- Stock : Request
-
Introduction
Avelumab biosimilar is a programmed death ligand-1 (PD-L1) blocking antibody and prevents its interaction with the inhibitory T-cell receptor, PD-1 (programmed cell death protein 1). Upon binding, avelumab promotes T-cell reactivation and restores T-cell-mediated immune response against tumor cells. Avelumab is also the only PD-L1 antibody so far to also induce antibody-dependent cell-mediated cytotoxicity (ADCC) against tumor cells expressing PD-L1.
General Information
| Reactivity | Human |
|---|---|
| Application | Functional Assay |
| Host | CHO cells |
| Clonality | Monoclonal |
| Conjugate | Non-conjugated |
| Isotype | Human IgG1 |
| Cas No. | 1537032-82-8 |
| Purity | >95%; < 0.75 EU/mg as determined by the LAL method |
| Molecular Weight | 150 kDa |
| Storage buffer | 0.01 M phosphate buffered saline (PBS) pH 7.2 |
| Storage instruction | This solution is stable for at least 4 weeks when stored at 2-8°C. For long term storage aseptically aliquot and store at –80°C.Avoid repeated freeze/thaw cycles. |
.png)